Bfsg, LLC Biomarin Pharmaceutical Inc Transaction History

Bfsg, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$71.87 - $131.03 $474,773 - $865,584	-6,606 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$79.55 - $124.22 $44,388 - $69,314	-558 Reduced 7.79%	6,606 $815,000
Q1 2020 Apr 27, 2020	SELL	$71.37 - $96.85 $6,494 - $8,813	-91 Reduced 1.25%	7,164 $605,000
Q4 2019 Jan 29, 2020	BUY	$64.27 - $86.37 $466,278 - $626,614	7,255 New	7,255 $613,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

Stay updated on Bfsg, LLC with notifications on news.